Quartz·1 min read·easy
CVS Health's profit nearly tripled as it launched an Eli Lilly weight loss drug deal
✦AI Summary
CVS Health reported a significant increase in second-quarter profits, nearly tripling compared to previous periods. The growth is attributed to a successful deal involving an Eli Lilly weight loss drug.
CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in